Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivani Medical Inc (VANI)

Vivani Medical Inc (VANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 101,616
  • Shares Outstanding, K 78,166
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,490 K
  • EBIT $ -27 M
  • EBITDA $ -27 M
  • 60-Month Beta 3.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 62.81

Options Overview Details

View History
  • Implied Volatility 394.79% (-284.39%)
  • Historical Volatility 72.03%
  • IV Percentile 85%
  • IV Rank 52.11%
  • IV High 692.63% on 12/11/25
  • IV Low 70.66% on 05/16/25
  • Expected Move (DTE 26) 0.3400 (26.15%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 54
  • Volume Avg (30-Day) 362
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 10,139
  • Open Int (30-Day) 6,884
  • Expected Range 0.9600 to 1.6400

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1600 +12.07%
on 02/12/26
1.5700 -17.20%
on 01/22/26
-0.0600 (-4.41%)
since 01/20/26
3-Month
1.1600 +12.07%
on 02/12/26
1.5700 -17.20%
on 01/22/26
-0.0500 (-3.70%)
since 11/20/25
52-Week
0.9054 +43.58%
on 04/04/25
1.9200 -32.29%
on 10/21/25
+0.1200 (+10.17%)
since 02/20/25

Most Recent Stories

More News
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology  Cortigent is the only company to have obtained FDA approval of a device providing artificial...

VANI : 1.3000 (unch)
Vivani Medical, Inc. Announces Closing of Common Stock Offering

ALAMEDA, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3000 (unch)
Vivani Medical, Inc. Announces Pricing of Common Stock Offering

ALAMEDA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3000 (unch)
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology  The company’s new Orion cortical stimulation system for visual perception, designed to...

VANI : 1.3000 (unch)
Vivani Medical: Q3 Earnings Snapshot

Vivani Medical: Q3 Earnings Snapshot

VANI : 1.3000 (unch)
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase 2...

VANI : 1.3000 (unch)
Vivani Medical, Inc. Announces Closing of Common Stock Offering

ALAMEDA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3000 (unch)
Vivani Medical, Inc. Announces Pricing of Common Stock Offering

ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3000 (unch)
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025

ALAMEDA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3000 (unch)
Vivani Medical Delays Cortigent Spin-Off Record Date

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Vivani Medical...

VANI : 1.3000 (unch)

Business Summary

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second...

See More

Key Turning Points

3rd Resistance Point 1.3848
2nd Resistance Point 1.3574
1st Resistance Point 1.3287
Last Price 1.3000
1st Support Level 1.2726
2nd Support Level 1.2452
3rd Support Level 1.2165

See More

52-Week High 1.9200
Fibonacci 61.8% 1.5324
Fibonacci 50% 1.4127
Last Price 1.3000
Fibonacci 38.2% 1.2930
52-Week Low 0.9054

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar